Citation Impact
Citing Papers
Osteoporosis and Depression: Shedding More Light Upon a Complex Relationship
2001
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
2003
Estrogen–serotonin interactions: implications for affective regulation
1998
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?
2008
Osteoporosis in Patients With Schizophrenia
2004
Crosstalk between TGF-β signaling and the microRNA machinery
2012
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
2013
Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions
2010
Oxidative stress, aging, and diseases
2018 Standout
Estrogen receptors and human disease
2006 Standout
Bone Mineral Density in Women with Depression
1996
No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects
2006
Accelerated Osteoporosis in Psychiatric Patients: Possible Pathophysiological Processes
1996
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Gait variability and fall risk in community-living older adults: A 1-year prospective study
2001 Standout
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis
2000
Quality-of-Life Impairment in Depressive and Anxiety Disorders
2005 Standout
Physical illness and schizophrenia: a review of the literature
2007
Descending control of pain
2002 Standout
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Selective serotonin reuptake inhibitors and neuroendocrine function
1999
The resurgence of platinum-based cancer chemotherapy
2007 Standout
High bone turnover but normal bone mineral density in women suffering from schizophrenia
2008
Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain
1998
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
2004
Depression and low bone mineral density: a meta-analysis of epidemiologic studies
2009
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Depression in Late Life: Review and Commentary
2003 Standout
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
2002
Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent
2001
Neuroprotection by estradiol
2001
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders
2003
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders
2000
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
2002
Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone
2003
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
2005
The multiple interactional biological processes that might lead to depression and gender differences in its appearance
1993
Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder
2002
Protective and Damaging Effects of Stress Mediators
1998 Standout
Ovarian steroids and serotonin neural function
1998
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
2003
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Depression in adolescence
2012 Standout
Depression: a major, unrecognized risk factor for osteoporosis?
2001
The Association of Bone Mineral Density and Depression in an Older Population
2001
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
2007
CLASSICAL AND ATYPICAL NEUROLEPTICS, AND BONE MINERAL DENSITY, IN PATIENTS WITH SCHIZOPHRENIA
2002
Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
2006
Major Depressive Disorder
2008 Standout
Schizophrenia and osteoporosis
2003
Gender differences in depression
2000 Standout
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Endometriosis
2004 Standout
Effects of Gonadal Steroids in Women With a History of Postpartum Depression
2000 Standout
Antipsychotic Drugs
2005
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?
2003
Health Professional's Guide to Rehabilitation of the Patient with Osteoporosis
2003
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
2016
Development of a Nomogram for Prediction of Vaginal Birth After Cesarean Delivery
2007
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites
2001
Endogenous microRNA sponges: evidence and controversy
2016 Standout
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Depression, Falls, and Risk of Fracture in Older Women
1999
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Risk of hip/femur fractures in patients using antipsychotics
2005
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
Estrogen Actions in the Central Nervous System1
1999 Standout
Antipsychotic-Induced Hyperprolactinaemia
2004
Depression and osteoporosis: epidemiology and potential mediating pathways
2007
The Premenstrual Syndrome and Fibromyalgia—Similarities and Common Features
2009
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Exercise: a behavioral intervention to enhance brain health and plasticity
2002 Standout
Risk of hip fracture in patients with a history of schizophrenia
2007
FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age
2011 Standout
Bone Mineral Density and Its Relationship to Prolactin Levels in Patients Taking Antipsychotic Treatment
2005
Lumbar Bone Mineral Density in Patients With Major Depression: Evidence of Increased Bone Loss at Follow-Up
2000
A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial
2010
Postpartum Depression: Current Status and Future Directions
2013 Standout
Sex differences in the psychopharmacological treatment of depression
2016
Efficacy of Intermittent, Luteal Phase Sertraline Treatment of Premenstrual Dysphoric Disorder
2002
Physical Illness and Schizophrenia
2007
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
Environment, lifestyle and infertility — an inter-generational issue
2002
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders
2007
miR‐483‐3p controls proliferation in wounded epithelial cells
2011
COLLAGEN IMPLANT FOR TREATING STRESS URINARY INCONTINENCE IN WOMEN WITH URETHRAL HYPERMOBILITY
2001
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
2005 Standout
Works of Nathan Rojansky being referenced
Estrogen augments serotonergic activity in postmenopausal women
1995
Periurethral Injection for the Treatment of Urinary Incontinence
1998
Seasonal variability in fertilization and embryo quality rates in women undergoing IVF
2000
Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050
2006
Comprehensive Gene and microRNA Expression Profiling Reveals a Role for microRNAs in Human Liver Development
2009
IUD use and the risk of endometrial cancer
2002
Increased imidazoline and α2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes
1993
How Often Are Endometrial Polyps Malignant?
2004
Decreased Bone Mineral Density in Medicated Psychiatric Patients
1995
Inhibitors that target protein kinases for the treatment of ovarian carcinoma
2003
Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects
1991
Imipramine Receptor Binding and Serotonin Uptake in Platelets of Women with Premenstrual Changes
1991
Predictive score for vaginal birth after cesarean section
1996